Papers

2

Total Citations

7

H-Index

1

About

Dr. Ali Merhe is a urologic surgeon and researcher whose work sits at the intersection of oncologic risk stratification and advanced robotic surgical technique. His primary research focuses on developing predictive tools for prostate cancer management, most notably through the creation of a novel nomogram that incorporates the platelet-to-lymphocyte ratio to forecast lymph node involvement in prostate carcinoma. This contribution, which has garnered 6 citations, offers clinicians a more nuanced, non-invasive method for staging disease and guiding treatment decisions. Beyond risk modeling, Dr. Merhe has made significant contributions to the field of minimally invasive surgery, as demonstrated by his report on a robotic partial nephrectomy with inferior vena cava thrombectomy. In this technically demanding case, he successfully resected a 4 cm renal mass with a level 1 IVC thrombus, showcasing the feasibility of robotic approaches for complex renal tumors. While his citation count is still building, Dr. Merhe’s work represents a dual commitment: refining prognostic accuracy through accessible biomarkers and pushing the boundaries of what is achievable with robotic platforms, positioning him as an emerging voice in urologic oncology.

Research Focus

Key Achievements

1
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma
6 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: American University of Beirut Medical Center, University of Miami

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago